1. Evaluation of sofosbuvir and simeprevir-based regimens in the TRIO network: academic and community treatment of a real-world, heterogeneous population;Dieterich;Hepatology,2014
2. Safety and efficacy of sofosbuvir-containing regimens for hepatitis C: real-world experience in a diverse, longitudinal observational cohort;Jenssen;Hepatology,2014
3. Ledipasvir/sofosbuvir fixed dose combination is safe and efficacious in cirrhotic patients who have previously failed protease-inhibitor based triple therapy;Bourliere;Hepatology,2014
4. Retreatment of patients who failed prior sofosbuvir-based regimens with all oral fixed-dose combination ledipasvir/sofosbuvir plus ribavirin for 12weeks;Wyles;Hepatology,2014
5. All-oral 12-week combination treatment with Daclatasvir and sofosbuvir in patients infected with HCV genotype 3: ALLY-3 phase 3 study;Nelson;Hepatology,2014